ORIONS Money Stocks

[420man]

LHDX-- If Eclipse Ventures (major shareholder) didn't buy Lucira before they filed BK, that means they (or another company) want to possibly aquire them for much less. They HAD to know Lucira was granted FDA approval of their Covid/flu OTC test kit, but still didn't buy them...or any other Company Lucira courted on their Jan 5th conference call.

I'd be super careful with LHDX at this point....they could sell the company for far less than their cash on hand of $4.5M... asset value of $146M minus liabilities of $85M leaving a net value of $61M and an OS of 40M. That puts them at around $1.50 per share... BUT...Stalking horses usually buy a company in BK for pennies on the dollar...usually around 5% of value, which equals .075 cents. Not to mention Covid/flu test kit demand is in the dumpster at this point.

It could pop more ($1 range, which is a double from current SP of .40 after jumping Friday afternoon from .14)..but it could also drop like a rock on the stalking horse buyer news. $$ to me made, but on what side of the play? Will be an interesting week going forward. Do your own DD. Tick Tock